Neurological Institute Outcomes
Epilepsy
Adult Epilepsy: Effect of Treatment on Quality of Life
Improvement in Quality of Life in Medically Treated Adult Epilepsy Patients (N = 4307)
2007 – 2022
QOLIE-10 = Quality of Life in Epilepsy questionnaire
Note: Lower score means improved quality of life.
In medically treated patients, the mean QOLIE-10 score changed from 22 at initial visit to 19.8 at last follow-up (P < 0.001). The median (Q1, Q2) was 20 (15, 27.5) at initial visit and 18 (14, 24) at follow-up.
N = patients with at least 6 months of follow-up.
Mean duration of follow-up was 72.6 months.
The standard box plots reflect the median and the 25th and 75th quartiles.
Improvement in Quality of Life in Surgically Treated Adult Epilepsy Patients (N = 637)
2007 – 2022
QOLIE-10 = Quality of Life in Epilepsy questionnaire
Note: Lower score means improved quality of life.
In surgically treated patients, the mean QOLIE-10 score changed from 27.9 at initial visit to 22.9 at last follow-up (P < 0.001). The median (Q1, Q2) was 28 (21, 35) at initial visit and 22 (16, 29) at follow-up.
N = patients with at least 6 months of follow-up.
Mean duration of follow-up was 48 months.
The standard box plots reflect the median and the 25th and 75th quartiles.
Clinically Meaningful Improvement in Quality of Life
2007 – 2022
| Patients Achieving Clinically Meaningful Improvement | |
|---|---|
Medically treated patients (N = 4307) | 47.3% |
Surgically treated patients (N = 637) | 59.8% |
Clinically meaningful improvement in quality of life is defined as a drop of at least 10% in the baseline QOLIE-10 Score.¹
